Russia has temporarily suspended vaccination of new volunteers at its COVID-19 vaccine trial, with staff at eight of the 25 test clinics saying some cited high demand and food shortages.
However, the vaccine the developer said that the newcomers have only slowed down.
In eight of Moscow's 25
clinics, staff hosting the trial and taxing volunteers told Reuters that new
participants had been temporarily barred’ from receiving polio drops, and
several said they had taken one of the volunteers. Referring to a large number,
he has used the allotted amount in his clinic.
The trial took place at
three Moscow clinics, with staff saying they had specifically removed the first
component of the two-dose jaw. The second component is injected’ 21 days after
the first day.
"Vaccination has been
temporarily suspended. We are only injecting the second component," a
staff member at Moscow Clinic # 109 told Reuters.
According to the RIA News
Agency, the director of the Gamaleya Institute, which is developing and
developing the vaccine, said the decision to slow down the vaccination of new
volunteers was a new step in giving a second dose to those already vaccinated.
Had to focus
"Everything is on
track. It's just that the difference between the first and second doses (the
number of people vaccinated) is significant," Alexander Ginsberg said
through the RIA. The Interfax news agency reported that the total number of
daily vaccinations had not changed.
'Collective demand'
Ginsberg said that so far
20,000 volunteers have received the first shot and the second 9,000. The
clinician hosting the trial needed to reduce the number of people receiving the
first ingredient.
"This is due to the
fact that there is a strong demand for vaccines and they are not producing
enough to sustain them," he said. A spokesperson for the organization Crocus
Medical said. The man did not give his name.
He said that according to
the provisional information, the drops would start reversing on November 10.
Two of the eight clinics contacted by Reuters also mentioned the first dose.
"Try again next
week!" A Reuter’s correspondent heard the staff make the announcement on
Tuesday, telling potential volunteers at a vaccination trial center in Moscow's
Chertanovo district.
Alexei Battalion, director
of Crooks Medical, denied that the trial was’ adjourned. "Trials are
ongoing, and there is ample supply of vaccines."
Russian officials and
vaccine developers have previously raised the challenge of increasing production
of the vaccine known as Sputnik V, and earlier this month set an initial
estimate of 30 million doses by the end of the year. More than 2 by the
Minister of Industry reduced me. Millions of doses.
Earlier on Thursday,
President Vladimir Putin said that Russia was facing challenges in increasing
vaccine production due to equipment availability problems, but hoped to launch
a large-scale vaccine by the end of this year. ۔
Alexei Kuznetsov, Russia's
assistant health minister said the vaccine was being tested’ in humans.
"The target of 40,000 immunization volunteers will be met," he said.
The Gamaleya Institute is
slowly joining forces with private Russian pharmaceutical companies, which are
ready to produce large-scale shots in their plants.
READ MORE
0 Comments